ERBB2 and metastatic malignant neoplasm: However, there are no data on the impact of chemotherapy on breast cancer survival in the real world, with the exception of a few population-based studies reviewing specific sub-groups such as metastatic cancer, HER2+ tumors, triple negative breast cancer or elderly patients [9] [10] [16].